Physician profile
Robert G Viere
NPI 1730146473
$38,292.27
in general payments reported to CMS, 2019-2025
8 companies · $6,940 in 2025
The $6,940 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $377 · 2020: $548 · 2022: $10K · 2023: $20K · 2024: $104 · 2025: $6,940.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $27K · Food and Beverage: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $26,909.60 |
| Food and Beverage | $166.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| The Institute of Musculoskeletal Science and Education | $37,730.69 | 2020-2025 | Spira |
| Spineology INC. | $243.55 | 2019 | |
| Stryker Corporation | $133.38 | 2019 | |
| Augmedics INC. | $72.59 | 2024 | Xvision |
| Depuy Synthes Sales INC. | $45.53 | 2025 | Matrixmidface |
| Convatec INC. | $31.64 | 2024 | |
| Integra Lifesciences Corporation | $17.72 | 2020 | |
| Ethicon US, LLC | $17.17 | 2025 | Surgiflo Hemostatic Matrix, Vistaseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Viere listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.